| __timestamp | Amneal Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 675200000 |
| Thursday, January 1, 2015 | 109679000 | 771800000 |
| Friday, January 1, 2016 | 118757000 | 1205500000 |
| Sunday, January 1, 2017 | 109046000 | 1146500000 |
| Monday, January 1, 2018 | 230435000 | 1125800000 |
| Tuesday, January 1, 2019 | 289598000 | 1166100000 |
| Wednesday, January 1, 2020 | 326727000 | 1175500000 |
| Friday, January 1, 2021 | 365504000 | 1111400000 |
| Saturday, January 1, 2022 | 399700000 | 1210100000 |
| Sunday, January 1, 2023 | 429675000 | 1274600000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Amneal Pharmaceuticals, Inc. and Perrigo Company plc have taken different paths in optimizing these costs. From 2014 to 2023, Amneal's SG&A expenses grew by approximately 408%, starting from a modest $84.6 million to a substantial $429.7 million. In contrast, Perrigo's expenses increased by about 89%, from $675.2 million to $1.27 billion.
While Perrigo's absolute expenses are higher, their growth rate is more controlled compared to Amneal. This suggests that Perrigo might be more efficient in managing their SG&A costs relative to their size. As the pharmaceutical industry continues to evolve, these companies' strategies in cost management will be pivotal in maintaining their competitive edge.
Breaking Down SG&A Expenses: Sanofi vs Amneal Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited